Subscribe
Home
Issues
Online First
Latest Issue
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
SABCS 2023 - HER2+ MBC
ASCO 2023 - Breast Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Prostate Cancer Diagnostics Monthly Minutes
Webinars
Quick Quizzes
Press Releases
AVBCC
Association for Value-Based Cancer Care
VBCM
Value-Based Care in Myeloma
Conference Correspondent
ASCO 2015
ASCO 2015 – Lung Cancer
ASCO 2015 - Lung Cancer
Results from KEYNOTE-021 Cohort D: a Phase 1 Study of Pembrolizumab plus Ipilimumab as Second-line Therapy for Advanced NSCLC
ASCO 2015 - Lung Cancer
,
ASCO
Conference Correspondent
Read Article
Clinical Correlation and Frequency of PD-L1 Expression in EGFR-Mutant and ALK-Rearranged NSCLC
ASCO 2015 - Lung Cancer
,
ASCO
Conference Correspondent
Read Article
Results from POPLAR: Efficacy, Safety, and Predictive Biomarker Results From a Randomized Phase 2 Study Comparing MPDL3280A vs Docetaxel in NSCLC
ASCO 2015 - Lung Cancer
,
ASCO
Conference Correspondent
Read Article
Checkmate 017: A Phase 3 Study of Nivolumab vs Docetaxel in Previously Treated Advanced or Metastatic Squamous Cell NSCLC
ASCO 2015 - Lung Cancer
,
ASCO
Conference Correspondent
Read Article
Final Overall Survival Results of the Phase 3 PROCLAIM Trial
ASCO 2015 - Lung Cancer
,
ASCO
Conference Correspondent
Read Article
Necitumumab in Metastatic Squamous NSCLC: Establishing a Value-Based Cost
ASCO 2015 - Lung Cancer
,
ASCO
Conference Correspondent
Read Article
Phase 1-1B Trial of Tivantinib in Combination with Carboplatin and Pemetrexed as First-Line Treatment in Patients with Advanced Nonsquamous NSCLC or Malignant Pleural Mesothelioma
ASCO 2015 - Lung Cancer
,
ASCO
Conference Correspondent
Read Article
A Phase 3B/4 Safety Trial of Nivolumab (NIVO) in Patients with Advanced or Metastatic NSCLC
ASCO 2015 - Lung Cancer
,
ASCO
Conference Correspondent
Read Article
Phase 3 Trial (Checkmate 057) of Nivolumab (NIVO) Versus Docetaxel (DOC) In Advanced Non Squamous Cell (Non-SQ) NSCLC
ASCO 2015 - Lung Cancer
,
ASCO
Conference Correspondent
Read Article
Page 2 of 2
1
2
View the Latest Issue of VBCC
Read Issue
Top Trending Articles
1.
Addressing Cancer Health Disparities: The No One Left Alone Initiative
Rohan Nathwani
,
Arva Patel
,
Warner Kornberg
,
Asutosh Gor, MD
,
Sashi Naidu, MD
,
Viral Rabara, MD
,
Niyati Nathwani, MD
,
Kashyap Patel, MD
2.
Navigating the Complex Landscape of Oral Cancer Medication
3.
Luspatercept Yields Improved Transfusion Independence Compared With Epoetin Alfa in Patients With Lower-Risk MDS
Phoebe Starr
Home
Issues
Online First
Latest Issue
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
SABCS 2023 - HER2+ MBC
ASCO 2023 - Breast Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Prostate Cancer Diagnostics Monthly Minutes
Webinars
Quick Quizzes
Press Releases
AVBCC
Association for Value-Based Cancer Care
VBCM
Value-Based Care in Myeloma